View on Pubmed.gov 24646670 | View on doi.org 10.1038/nrn3707
Growth and folding of the mammalian cerebral cortex: from molecules to malformations.
- Department of Cell and Developmental Biology, Weill Medical College of Cornell University, 1300 York Avenue, BOX 60, New York, New York 10065, USA.
- Department of Neurological Surgery and Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington 98101, USA.
Abstract
The size and extent of folding of the mammalian cerebral cortex are important factors that influence a species' cognitive abilities and sensorimotor skills. Studies in various animal models and in humans have provided insight into the mechanisms that regulate cortical growth and folding. Both protein-coding genes and microRNAs control cortical size, and recent progress in characterizing basal progenitor cells and the genes that regulate their proliferation has contributed to our understanding of cortical folding. Neurological disorders linked to disruptions in cortical growth and folding have been associated with novel neurogenetic mechanisms and aberrant signalling pathways, and these findings have changed concepts of brain evolution and may lead to new medical treatments for certain disorders.
References
Neuron. 1999 May;23(1):19-29
J Neurosci. 2013 May 8;33(19):8442-53
Neuron. 2009 Jul 16;63(1):48-62
Brain Res. 1978 Sep 8;152(3):451-85
Cited by 462 citations (total)
Journal Article
Noncoding variants and sulcal patterns in congenital heart disease: Machine learning to predict functional impact.
Electronic publication date January 29, 2025
Enrique Mondragon-Estrada [...] Sarah U Morton et al.
Neurodevelopmental impairments associated with congenital heart disease (CHD) may arise from perturbations in brain developmental pathways, including the formation of...
Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't
Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells.
Electronic publication date September 30, 2016
Chad M Toledo [...] Patrick J Paddison et al.
To identify therapeutic targets for glioblastoma (GBM), we performed genome-wide CRISPR-Cas9 knockout (KO) screens in patient-derived GBM stem-like cells (GSCs)...
Conflict of interest statement
MeSH
- •
- •
- •
Specialties
- •
- •